Genesis Adds Major Pharmaceutical Company to Its Partnering Program


BEIJING, May 17, 2007 (PRIME NEWSWIRE) -- Genesis Technology Group, Inc. (OTCBB:GTEC) announced it has signed a leading Chinese pharmaceutical company as the sixth member of its private-to-public partnering program. Based on information provided by the Chinese company, fiscal 2006 revenues topped $92 million and net profits exceeded 16%.

"Our newest partner company is decidedly our largest to date," remarked Dr. Shaohua Tan, Genesis Director in Beijing. "Our U.S. executive team soon will assemble in China to conduct discussions on how to best utilize this well-established pharmaceutical company in our capital and growth program.

"Gold Horse International, GTEC's partner company engaged in construction and real estate development in Western China, has reached the final stage in the private-to-public program. Interested parties should remain alert as announcements are expected to be made near term. Genesis' other partner companies -- China Environmental Technologies, Oriental Health Beverages and Sino Steel Structures -- are at various stages of the U.S. auditing process.

"We cannot offer a timeline for any of these partner companies to graduate to U.S. public company status. With CSRC regulations and the challenges of performing due diligence on each prospect, it remains a difficult and expensive process. Lotus (OTCBB:LTUS) remains a symbol of our success, and we are confident our other partner companies can join its rank in the future," concluded Dr. Tan.

About Genesis Technology Group, Inc.

Genesis Technology Group, Inc. (d/b/a Genesis China and GTEC) is a U.S. public company that earns, enhances and markets equity positions in small to mid-sized Chinese enterprises. Commitment, dedication, and expertise are the key components to the Genesis "Mission Statement." It has created a successful profit center by incubating Chinese companies in a wide range of sectors, creating so-coined "partner companies." Genesis makes a long-term commitment with management consultation, board of directors composition, creation and implementation of successful business models, which include expansion of markets in China and abroad. To help drive the success and profitability of these operations, Genesis provides resources and proficiency to maximize partners' leadership potential in China and attempts to increase high-margin, predictable earnings. For more information, visit http://www.Genesis-China.net.

Safe Harbor Statement

Certain statements set forth in this press release constitute "forward-looking statements." Forward-looking statements include, without limitation, any statement that may predict, forecast, indicate, or imply future results, performance or achievements, and may contain the words "estimate," "project," "intend," "forecast," "anticipate," "plan," "planning," "expect," "believe," "will likely," "should," "could," "would," "may" or words or expressions of similar meaning. Such statements are not guarantees of future performance and are subject to risks and uncertainties that could cause the company's actual results and financial position to differ materially from those included within the forward-looking statements. Forward-looking statements involve risks and uncertainties, including those relating to the Company's ability to grow its business. Actual results may differ materially from the results predicted and reported results should not be considered as an indication of future performance. The potential risks and uncertainties include, among others, the Company's limited operating history, the limited financial resources, domestic or global economic conditions -- especially those relating to China, activities of competitors and the presence of new or additional competition, and changes in Federal or State laws, restrictions and regulations on doing business in a foreign country, in particular China, and conditions of equity markets. More information about the potential factors that could affect the Company's business and financial results is included in the Company's filings, available via the United States Securities and Exchange Commission.



            

Coordonnées